ANI Pharmaceuticals, Inc. (ANIP) reported fourth quarter net income to shareholders of $749 thousand compared to a loss of $4.65 million, last year. Profit per share was $0.04 compared to a loss of $0.28. Adjusted earnings per share was $1.00 compared to $0.76. On average, four analysts polled by Thomson Reuters expected the company to report profit per share of $0.85, for the quarter. Analysts' estimates typically exclude special items.
Net revenues increased to $131.65 million from $94.23 million, last year. Analysts on average had estimated $122.21 million in revenue.
For 2024, the company expects: net revenues of $520 million to $542 million, and adjusted non-GAAP earnings per share of $4.26 to $4.67.
Shares of ANI Pharmaceuticals are up 6% in pre-market trade on Thursday.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.